The CeliAction Study Continues to Seek Subjects with Celiac Disease

This is the 3rd of four sponsored posts on my page about the CeliAction Study.  The CeliAction Study is seeking people with celiac disease to enroll in their study of ALV003, a drug to prevent intestinal damage and symptoms from accidental gluten cross-contamination. All comments and questions will be replied to by a CeliAction study representative. Thank you and I hope you are all well. -Jess

CAstudymidmay

Even when you try your best to stay gluten-free, you never know for sure if something you’ve eaten has been cross-contaminated or mislabeled until after the fact. Most people with celiac disease can relate to accidentally ingesting gluten and then paying the price later on.

Well, there is research currently underway to evaluate if an investigational drug can reduce the symptoms of unintentional exposure to gluten. If proven effective, the drug would offer a new way to manage celiac disease and supplement a gluten-free diet by reducing the risk of gluten’s impact on the body. The best part is that you have to stay on your gluten-free diet in order to participate – no gluten challenge!

The clinical research study is called the CeliAction Study and you may qualify if you:

  • Have been diagnosed with celiac disease by a healthcare professional
  • Are attempting to be on a gluten-free diet
  • Have experienced at least one moderate or severe symptom of celiac disease in the past month

If you participate in the CeliAction Study, you:

  • Will be able to maintain your current diet restrictions
  • Will be provided with study-related care at no cost
  • Do not need medical insurance to take part
  • May be compensated for time and travel
  • Will help advance medical research for celiac disease

To learn more about this research study and see if you qualify, visit CeliActionStudy.com
or call 1-855-3333-ACT.